Tetramethylkaempferol

CAS No. 16692-52-7

Tetramethylkaempferol( —— )

Catalog No. M23749 CAS No. 16692-52-7

Tetramethylkaempferol is a PPARγ agonist, it can improve insulin sensitivity by increasing the levels of adiponectin, an important adipocytokine associated with insulin sensitivity in adipose tissue.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 259 In Stock
5MG 227 In Stock
10MG 337 In Stock
25MG 559 In Stock
50MG 779 In Stock
100MG 1051 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tetramethylkaempferol
  • Note
    Research use only, not for human use.
  • Brief Description
    Tetramethylkaempferol is a PPARγ agonist, it can improve insulin sensitivity by increasing the levels of adiponectin, an important adipocytokine associated with insulin sensitivity in adipose tissue.
  • Description
    Tetramethylkaempferol is a PPARγ agonist, it can improve insulin sensitivity by increasing the levels of adiponectin, an important adipocytokine associated with insulin sensitivity in adipose tissue. Tetramethylkaempferol can concentration-dependently enhance the accumulation of triglyceride, a marker of adipogenesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    GLUT|PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16692-52-7
  • Formula Weight
    342.34
  • Molecular Formula
    C19H18O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc(cc1)ccc1C(Oc(cc(cc1OC)OC)c1C1=O)=C1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Search for new type of PPARγ agonist-like anti-diabetic compounds from medicinal plants. Biol Pharm Bull. 2014;37(6):884-91.
molnova catalog
related products
  • SR 16832

    SR 16832 is a dual-site PPARγ inhibitor. It also inhibits the binding of endogenous ligands and transcriptional activity of PPARγ, more effectively than the orthosteric covalent antagonist GW 9662 and T 0070907.

  • BAY-0069

    BAY-0069 is a potent and selective PPARγ transactivator, inhibiting human PPARγ and murine PPARγ with IC50 values of 6.3 nM and 24 nM, respectively. BAY-0069 can be used in cancer research.

  • Tetradecylthioacetic...

    Tetradecylthioacetic acid is a synthetic fatty acid with a sulfur substitution in the β-position. This modification renders TTA unable to undergo complete β-oxidation and increases its biological activity, including activation of peroxisome proliferator activated receptors (PPARs) with preference for PPARα.